Now posted on www.antitrustinstitute.org: October 29, 2004 Could the U.S. Government Have Prevented the Flu Vaccine Shortage? An Industrial Organization Perspective In a press release accompanying AAI Working Paper #04-03 by F.M. Scherer, AAI President Albert Foer discusses policy considerations that appear to flow from Dr. Scherer's paper.
October 29, 2004 AAI Working Paper 04-03. An Industrial Organization Perspective on the Influenza Vaccine Shortage, by F. M. Scherer In this Working Paper, AAI Senior Fellow F.M. Scherer examines various reasons advanced for the current shortage of flu vaccine in the U.S., finding that multiple sourcing with excess capacity built-in would yield more benefits than it costs.
